Brief: Neovacs Signs Two World Exclusive Licenses In The Field Of Asthma And Food Allergies
26/01/2022 07:12
Jan 26 (Reuters) - NEOVACS SA ALNEV.PA :
* SIGNS TWO WORLD EXCLUSIVE LICENSES IN THE FIELD OF ASTHMA
AND
FOOD ALLERGIES
* CONFIRMS ITS AMBITION TO ACCELERATE PRE-CLINICAL PROGRAMS
FOR
VACCINE CANDIDATES IN THE FIELD OF ALLERGIES (ASTHMA, ATOPIC
DERMATITIS AND FOOD ALLERGIES)
Source text for Eikon: ID:nACT72893
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants